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N-glycan mediated adhesion 
strengthening during pathogen-
receptor binding revealed by cell-
cell force spectroscopy
Joost te Riet  1,3, Ben Joosten2, Inge Reinieren-Beeren1, Carl G. Figdor1 &  
Alessandra Cambi  2
Glycan-protein lateral interactions have gained increased attention as important modulators of 
receptor function, by regulating surface residence time and endocytosis of membrane glycoproteins. 
The pathogen-recognition receptor DC-SIGN is highly expressed at the membrane of antigen-
presenting dendritic cells, where it is organized in nanoclusters and binds to different viruses, bacteria 
and fungi. We recently demonstrated that DC-SIGN N-glycans spatially restrict receptor diffusion within 
the plasma membrane, favoring its internalization through clathrin-coated pits. Here, we investigated 
the involvement of the N-glycans of DC-SIGN expressing cells on pathogen binding strengthening 
when interacting with Candida fungal cells by using atomic force microscope (AFM)-assisted single 
cell-pathogen adhesion measurements. The use of DC-SIGN mutants lacking the N-glycans as well as 
blocking glycan-mediated lateral interactions strongly impaired cell stiffening during pathogen binding. 
Our findings demonstrate for the first time the direct involvement of the cell membrane glycans in 
strengthening cell-pathogen interactions. This study, therefore, puts forward a possible role for the 
glycocalyx as extracellular cytoskeleton contributing, possibly in connection with the intracellular actin 
cytoskeleton, to optimize strengthening of cell-pathogen interactions in the presence of mechanical 
forces.
Understanding how the plasma membrane composition and its spatial organization control receptor function 
is an area of intense investigation. Nanoscale clustering, localization within specific membrane lipid domains, 
anchoring to cortical actin structures and lateral mobility patterns have been shown to modulate the func-
tion of membrane receptors including integrins1–3, growth factor receptors4, 5, immune receptors6–8, as well as 
pathogen-recognition receptors (PRRs)9–11. Glycosylation of plasma membrane proteins is known to increase 
their residence time at the plasma membrane, facilitate cell-cell adhesion through lectin-glycan interactions, and 
regulate endocytosis of receptors such as EGFR or CD4412, 13. If in the latter case, lateral interactions between 
plasma membrane proteins within the glycan-protein layer of a cell, i.e. glycocalyx, also play a role in regulating 
adhesion is still mainly unknown.
Dendritic Cell-Specific ICAM-3-Grabbing Non-Integrin (DC-SIGN; CD209) is a type II plasma membrane 
PRR abundantly expressed in antigen-presenting cells such as dendritic cells (DCs) and activated macrophages14, 15. 
As member of the C-type Lectin Receptor (CLR) family, DC-SIGN binds a plethora of pathogens, ranging from 
viruses like HIV-116, ebola virus17, and hepatitis C virus18, to larger pathogens like Mycobacterium tuberculosis19 
and Candida albicans20. DC-SIGN directly binds glycan structures exposed at the pathogen surface. Structurally, 
DC-SIGN is a tetramer, with each monomer having a long extracellular part composed by a carbohydrate recog-
nition domain (CRD), a 7.5 tandem repeat of 23 amino acids forming the neck region, and a transmembrane part 
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followed by a cytoplasmic tail containing a recycling and internalization motif (Fig. 1)21, 22. The neck region (i.e. 
repeat region) of DC-SIGN is responsible for its tetramerization23 enabling the clustering of CRDs to present mul-
tiple binding sites and increasing the interaction strength with specific ligands24. In addition, DC-SIGN harbors 
a glycosylation motif at the membrane proximal part of the repeat region, with the Asn80 residue undergoing 
N-glycosylation25. Moreover, DC-SIGN forms nanoclusters at the cell membrane (Fig. 1), which are crucial for 
virus binding9, 26, 27. Similarly, DC-SIGN nanocluster formation and/or stability do not require interactions with 
the cortical cytoskeleton or association with tetraspanins28. We recently showed that impaired N-glycosylation 
of DC-SIGN significantly altered the lateral mobility pattern and ultimately the capacity of the receptor to follow 
clathrin-mediated endocytosis29. Considering the importance of lateral mobility for receptor-ligand interactions, 
we hypothesize a role of plasma membrane glycans in regulating the adhesion strength between receptors and 
pathogen.
Adhesive interactions between cells, including immune cells and pathogens, mostly occur in a dynamic envi-
ronment caused by, for example, flowing body fluids, and thus bonds will experience mechanical loading. Cell 
adhesion can be regulated by mechanisms such as (i) up- or down-regulation of the surface expression of cell 
adhesion molecules (CAMs), (ii) changing affinity of the CAM, or (iii) clustering of CAMs30. The latter two can 
be influenced by interactions of the cytoplasmic part of the CAM with the underlying actin cytoskeleton7, 31. 
Since adhesion is not a static process, though dynamic, experimental methods probing adhesive interactions 
between single cells might provide detailed insight into the complexity of adhesion regulation. A very promising 
technique to explore this is atomic force microscopy (AFM)-assisted single-cell force spectroscopy (SCFS)32, 33 
that can probe the interaction between a cell and isolated CAMs33–36 or extracellular matrix proteins37–39, between 
cells40–42, and between cell and pathogen43–45. Moreover, hybrid AFM-light microscopy allows manipulating cells 
with submicron accuracy while monitoring cellular responses and allows measuring interactions forces up to the 
single-molecule level. AFM-assisted SCFS with a single C. albicans fungal cell on an AFM cantilever allowed us to 
study the recognition strength of DC-SIGN under mechanical load showing that DC-SIGN specifically discrim-
inates between carbohydrate moieties in the cell wall of the fungus Candida albicans that have similar chemical 
composition but slightly different structures34. Infections caused by Candida are the main cause of mortality due 
to invasive mycotic diseases for severely immunocompromised patients20, 46, 47. Studies on the initial binding of 
different Candida species (e.g., C. albicans, C. paropsilosis, and C. dubliniensis) with DCs showed that DC-SIGN 
as well as the macrophage mannose receptor (MMR; CD206) are involved with the detection of fungal Candida 
cells20, 47.
In this study, we used cell-cell force spectroscopy (CCFS) to investigate the involvement of the glycocalyx 
of DC-SIGN expressing cells on pathogen binding strengthening when interacting with single Candida fun-
gal cells. We show that N-glycosylation of DC-SIGN plays a previously unidentified role in strengthening 
DC-SIGN-pathogen binding by providing an additional layer of glycan-mediated lateral interactions between 
Figure 1. Structure and membrane nanoscale organization of DC-SIGN. (A) DC-SIGN is type-II C-type lectin 
(N-terminus is intracellular) that has an extracellular Carbohydrate Recognition Domain (CRD), a region of 
7.5 amino acid repeats, preceded by a site for N-glycosylation (amino acid N80), a transmembrane region and a 
short cytoplasmic tail. In this study, besides the wild-type, several mutants of DC-SIGN were used: DC-SIGN-
ΔCRD, which lacks the ligand binding domain; DC-SIGN-N80A, which carries a point mutation that abolish 
N-glycosylation; and DC-SIGN-ΔRep, which only lacks the repeat region25. (B) Except for DC-SIGN-ΔRep, all 
the other variants can form tetramers and organize in small nanoclusters within the plasma membrane10.
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DC-SIGN and other plasma membrane constituents. This most likely results in cross-linking of DC-SIGN to 
transmembrane glycoproteins that are stably associated with the cortical actin cytoskeleton. This is the first 
report to our knowledge that documents the direct involvement of the cell membrane glycans in strengthening 
cell-pathogen binding interactions. Understanding how the plasma membrane nano-environment contributes 
to the regulation of receptor function will provide novel insights that are relevant for both membrane biologists 
and immunologists.
Results
AFM force spectroscopy to quantify cell-pathogen interaction strength. Our recent AFM stud-
ies revealed the interaction affinity between C. albicans cells and recombinant single DC-SIGN molecules34. To 
determine the recognition strength of DC-SIGN-mediated pathogen-immune cell interactions at the cell-cell 
level, we applied AFM-assisted cell-cell force spectroscopy (CCFS)32, 40. Therefore, an intact C. albicans cell was 
immobilized underneath the apex of a concanavalin A (ConA)-functionalized tip-less AFM cantilever and sub-
sequently brought into contact with a flat part of a single immature dendritic cell (imDC) attached to a glass 
coverslip (Fig. 2A). Both MMR and DC-SIGN are known to specifically bind glycan structures in the cell wall 
of Candida albicans20, 47. A combined brightfield-AFM microscope was used to position the C. albicans cell over 
the imDC and subsequent to bring them into contact, all with submicron accuracy (Fig. 2B and Suppl. Movie 1). 
The interaction strength between imDC and C. albicans was measured by quantifying the work and maximum 
detachment force Fmax from single force-distance (FD)-curves (Fig. 2C). Many imDC-Candida interactions were 
measured in medium leading to an average Fmax (Fig. 2D) and work (Fig. 2E). To take donor-dependent hetero-
geneity of CLR expressions levels into account, we normalized results of different imDCs for which detachment 
forces varied between ~1–4 nN under unblocked conditions. To test for specificity of the interactions, 150 µg/ml 
soluble CA-mannan was added 20 min in situ to the cells to block DC-SIGN binding47 and interactions between 
C. albicans and the same imDCs were probed again. After blocking with soluble CA-mannan, both Fmax and work 
are reduced (Fig. 2D,E). To distinguish between the contribution of DC-SIGN and MMR receptors on imDCs 
that bind C. albicans, interactions were specifically blocked with 30 µg/ml anti-DC-SIGN antibody (AZN-D1), 
30 mM mannose to block MMR, or a combination of both. To note, these concentrations have been shown to be 
saturating in previous experiments20, 47. In presence of these inhibitors, FD-curves clearly show less work and 
lower Fmax (Fig. 2C). Residual interactions after blocking might be due to suboptimal blocking efficiency and 
some weak a-specific interactions. When specifically looking at the work, we observe that under mechanical load 
DC-SIGN and MMR equally contribute to binding C. albicans (Fig. 2E). Under steady conditions such as meas-
ured with flow cytometry, however, MMR seems to be the main contributor to binding (Fig. 2F). In accordance 
with this, inspection of the detachment force Fmax also reflects a stronger effect of MMR, which can be explained 
by a stronger association rate or a higher expression level of the MMR with respect to DC-SIGN.
Discrete rupture steps in the FD-curves (arrows; see Fig. 2C) represent the unbinding of single or multiple 
receptor-ligand bonds that are disrupted upon detachment of the C. albicans from the imDC. Figure 2G shows 
the analysis of rupture forces before and after blocking DC-SIGN, MMR or both. Rupture forces measured on 
imDCs in medium conditions show a maximum peak around 110 pN, whereas imDCs blocked for DC-SIGN 
or MMR show a maximum peak in rupture forces around 130 pN and 105 pN, respectively. Note that when we 
normalize to the amount of rupture steps per FD curve we see that steps under blocked conditions are much less 
abundant in FD-curves (Fig. 2G; dotted lines). When both DC-SIGN and MMR are blocked the maximum peak 
in the rupture forces shifts to 80 pN. These rupture events most likely originate from unspecific binding events 
with lower affinity. With similar reasoning and having observed that MMR has a stronger effect on the Fmax, we 
would expect that MMR-C. albicans bonds are slightly stronger than DC-SIGN-C. albicans bonds; we indeed find 
rupture forces of 130 versus 105 pN for MMR and DC-SIGN, respectively. Knowing that the detachment force 
is in the order of 1–4 nN, only tens to hundreds of individual specific bonds are formed between the cell and C. 
albicans.
In summary, by AFM-assisted CCFS we show that both DC-SIGN and MMR are main players in the binding 
to C. albicans with slightly different contributions to the capturing strength under mechanical load. Moreover, 
these results demonstrate the usefulness of AFM-assisted CCFS to obtain a better insight into the dynamic bind-
ing of pathogen and receptor.
The various domains in the molecular structure of DC-SIGN differently influence the binding 
strength to Candida albicans. To be able to study the recognition of C. albicans by DC-SIGN without 
interference of MMR and with more expression homogeneity in the cell populations, CHO cells were stably 
transfected with DC-SIGN wild-type (DC-SIGN-WT) as we previously reported10, 48. Ensemble binding stud-
ies by flow cytometry of CHO-DC-SIGN-WT cells with C. albicans show the specific binding of C. albicans by 
DC-SIGN through blocking by an anti-DC-SIGN antibody or by addition of the Ca2+ and Mg2+ chelator EDTA 
(Fig. 3A). To study the recognition of C. albicans by DC-SIGN-WT at the single cell level, we used CCFS (Fig. 3B 
and Suppl. Movie 2), with a single C. albicans cell immobilized on the cantilever and brought it into contact for 
10 seconds with different CHO cells expressing DC-SIGN-WT (Fig. 3C). Figure 3D shows that after blocking with 
anti-DC-SIGN, FD-curves have a lower interaction strength (Fmax and work) and are more similar to FD-curves 
of parental CHO cells as expected, confirming the applicability of CCFS also in the CHO-DC-SIGN cell system.
Different domains and glycosylation in the molecular structure of DC-SIGN might influence binding to C. 
albicans. To study this, different mutants of DC-SIGN were expressed in CHO cells. Next to DC-SIGN-WT, 
three mutants were generated: one lacking the CRD domain (DC-SIGN-ΔCRD), one lacking the repeat region 
(DC-SIGN-ΔRep), and one lacking the single N-glycosylation site at amino acid N80, which is mutated to ala-
nine (DC-SIGN-N80A). Cell surface expression of all these constructs was overall the same as confirmed by 
flow cytometry (Suppl. Fig. S1). Flow cytometry binding studies of these CHO-DC-SIGN cells with C. albicans 
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Figure 2. Both DC-SIGN and MMR contribute to the recognition strength of C. albicans by immature 
dendritic cells (imDC). (A) Schematic set-up showing a single C. albicans cell immobilized on a tip-less AFM 
cantilever interacting with an imDC expressing different C-type lectins such as DC-SIGN and MMR. (B) 
Example brightfield image that shows how a C. albicans cell on the tip (indicating by dashed white ellipse) 
interacts with different imDCs. The positions at which the C. albicans is brought into contact for 10 seconds 
with three imDCs are indicated by asterisks. (C) Example FD-curves of C. albicans - imDC interactions are 
shown of without (medium control) and with specifically blocking DC-SIGN and MMR (with 30 µg/ml anti-
DC-SIGN and 30 mM mannose for 30 minutes). In FD-curves the work and Fmax are measured such as indicated 
by the shaded area and depth of the curve, respectively. The zoom shows single membrane tether rupture steps 
(arrows). (D,E) The relative detachment force (D) and work (E) needed to detach an C. albicans cell from the 
imDC before and after blocking by CA-mannan, anti-DC-SIGN, mannose, or a combination of mannose and 
the antibody (N ≥ 3 independent experiments; N ≥ 20 cells; N≥ 20 FD-curves per condition). Significance 
levels by Mann-Whitney (n.s. = not significant; *p < 0.05; **p < 0.01; ***p < 0.001). (F) imDC cells were 
incubated with FITC-labeled C. albicans in the presence or absence of blocking agents; anti-DC-SIGN antibody, 
mannose and EGTA. The percentage of cells that bound C. albicans was calculated by flow cytometry. Data 
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show the specific binding of C. albicans on cells expressing DC-SIGN with an intact CRD domain only (Fig. 4A). 
Similar to these flow cytometry studies, CCFS studies show that CHO cells expressing DC-SIGN with a CRD 
domain, i.e., DC-SIGN-WT, -N80A, and -ΔRep, interact stronger with C. albicans cells (Fig. 4B–D) than 
CHO-DC-SIGN-WT cells blocked with anti-DC-SIGN or CHO-DC-SIGN-ΔCRD, the latter two showing both 
only background level of binding (Fig. 4B). Next,we plotted work as well as Fmax to compare DC-SIGN-WT with 
the mutants (Fig. 4C,D). As expected, both Ab-blocked DC-SIGN-WT and DC-SIGN-ΔCRD showed negligible 
work and Fmax values. Interestingly, while DC-SIGN-WT and DC-SIGN-N80A exhibited the same work (Fig. 4C), 
the average Fmax value was lower for the N-glycosylation-impaired mutant (Fig. 4D). This could be explained by 
considering that although a similar amount of DC-SIGN molecules bound to C. albicans, they are less capable 
of withstanding the pulling forces exerted by the AFM cantilever. This could explain why the Fmax is lower in the 
case of DC-SIGN-N80A.
When we compare the results of cells expressing DC-SIGN-ΔRep with those expressing DC-SIGN-WT or 
-N80A, CHO-DC-SIGN-ΔRep cells are less capable binding C. albicans, as reflected in a lower work and detach-
ment force compared to DC-SIGN-WT (Fig. 4C,D). However, when comparing to DC-SIGN-N80A, Fmax is sim-
ilar (Fig. 4D), but the work is significantly less for ΔRep (Fig. 4C). Earlier studies showed that DC-SIGN without 
its repeat domain cannot tetramerize24, 49. Tetramerization of DC-SIGN is known to contribute to a higher bind-
ing capacity for different ligands49, which could explain the lower work. Our measurements allow to analyze the 
strength of single interactions in FD-curves (Fig. 4E); maximum peaks are found around 110 pN rupture force in 
all cases, with no clear differences. The explanation for this observation is that the rupture forces measured here 
are a mix of ruptures depending on the affinity of bonds and of membrane tether ruptures that depend on retrac-
tion speed and membrane properties, which are the same for the different CHO-DC-SIGN cell lines33, 50. The 
lower abundance of rupture steps per FD-curve for CHO-DC-SIGN-ΔRep in contrast to WT and N80A relates 
to its lower adhesion as reflected in the work (Fig. 4B,C). In summary, the various domains of DC-SIGN seem 
to differently affect the overall adhesion to C. albicans; the CRD domain crucial for binding whereas the repeat 
region and N-glycosylation site clearly contribute to the mechanic strength.
Tetramers of DC-SIGN are stronger anchors of membrane tethers than monomers. To better 
determine and quantify whether DC-SIGN-WT and its mutants differ in their ability of withstanding pulling 
forces, FD-curves for each cell line were averaged and aligned at the x-axis position of Fmax (Fig. 5A) or at the 
position of maximum contact force of 2 nN (Fig. 5B). In Fig. 5B the presence of a sharper dip in the FD-curve 
for DC-SIGN-WT, which is less pronounced for DC-SIGN-N80A, is clearly visible. To note is that averaging at 
the Fmax-position (Fig. 5A) keeps the average detachment force and work corresponding to the data of Fig. 4C 
and D, whereas averaging at the 2nN-position (Fig. 5B) ‘smears’ the sharp peak33. The averaged FD-curves of 
DC-SIGN-ΔCRD show the signature of non-specific background adhesion, which is small. Inspecting the depth 
of the minimum peak shows that interactions of DC-SIGN-ΔRep and DC-SIGN-N80A have similar depths, 
which are both lower than that of DC-SIGN-WT (Fig. 5A,B) and relates to the differences in Fmax found (Fig. 4D). 
However, in the case of DC-SIGN-N80A and DC-SIGN-WT more interactions are present over longer retraction 
distances, 2–15 µm away from the cell (Fig. 5A,B). This implies that for these cells a larger part of the cellular 
membrane is pulled along with the C. albicans upon retraction of the AFM cantilever. These pieces of membrane 
that are pulled from the CHO-DC-SIGN-WT and -N80 cell are probably anchored to the C. albicans by DC-SIGN 
molecules. The disconnection of these anchors upon pulling results in small rupture steps in the FD-curves (see 
Fig. 2C). We previously demonstrated that at distances >5 µm most of these events result from disconnecting 
membrane tethers33. Therefore, we next analyzed the mean number of membrane tethers in these FD-curves and 
found that for DC-SIGN-ΔRep membrane tethering is comparable to non-specific (background) membrane 
tethering of DC-SIGN-ΔCRD cells, which are not capable of forming DC-SIGN-anchored membrane tethers 
because of the absence of the CRD-domain (Fig. 5C). Knowing that the lifetime of a membrane tether relates 
to the lifetime of the bond(s) anchoring it, we conclude that less membrane tethers relate to weaker bonds50. 
Therefore, although DC-SIGN-ΔRep is expressed at similar levels as DC-SIGN-WT, these cells have a lower 
intrinsic adhesion strength Fmax and are less capable of forming DC-SIGN-anchored membrane tethers, which 
can be explained by DC-SIGN-ΔRep being monomeric whereas DC-SIGN-WT and -N80A forming tetramers. 
These results collectively show that DC-SIGN-WT and -N80A have the same capacity to form membrane tethers, 
which is higher than the ΔRep mutant. This also indicates that tetramerization but not N-glycosylation has a role 
in membrane tethering formation.
Glycosylation of DC-SIGN contributes to a stronger connection to the actin cortex. We demon-
strated so far that N-glycosylation of DC-SIGN is important for the receptor to withstand pulling forces, but 
has no role in membrane tethering during DC-SIGN-Candida detachment. Therefore, we sought to investigate 
whether N-glycosylations plays a role in the overall cell stiffening in response to pathogen binding and mechan-
ical retraction. Analysis of averaged FD-curves can provide insight in the elasticity of the microenvironment of 
the receptor binding sites33, 51. Therefore, we fitted the (semi-)linear regime of averaged FD-curves over a distance 
from 0 µm to the distance at which the highest force acts on the bonds; i.e. the distance at which we measure Fmax 
are normalized to medium conditions. (G) Loading probability distribution of all rupture steps detected in 
the FD-curves prior to and after blocking show different distributions that peak at 112 pN (medium), 102 pN 
(MMR block), 122 pN (DC-SIGN block), and 76 pN (both blocked) (N > 450 rupture steps). The normalized 
probability plots are shown and the ‘dashed’ curves are scaled relative to the number of rupture steps per FD-
curve (arbitrary units).
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(Fig. 6A; dotted lines), thus obtaining elasticity values. This gives insight in how DC-SIGN-expressing cells cope 
with forces that build up at the adhesion site with C. albicans. We found that the elasticity of DC-SIGN-WT bonds 
holding to C. albicans is almost 3-fold higher than that of DC-SIGN-N80A (Fig. 6B), whereas DC-SIGN-ΔRep 
has a similar elasticity as DC-SIGN-WT (Fig. 6B). Interestingly, since the mutant DC-SIGN-ΔRep maintained its 
N-glycosylation, the elasticity measurements suggest that glycan interactions may indeed play a role in strength-
ening cell-cell contacts under mechanical load.
We showed before that pretreatment of CHO-DC-SIGN-WT cells with 100 mM lactose overnight can effec-
tively dissolve the lateral interactions of galectins with glycans present on the cellular membrane, resulting for 
example in changes of nanoscale lateral mobility behavior of DC-SIGN29. Here, we treated CHO-DC-SIGN-WT 
cells with lactose and analyzed the adhesion to C. albicans by AFM-assisted CCFS. We observe that FD-curves 
of lactose-treated CHO-DC-SIGN-WT cells have a similar unbinding ‘signature’ as CHO-DC-SIGN-N80A 
(Fig. 6C). Moreover, they also exhibited a lower elasticity (Fig. 6B) and the absence of a sharp Fmax peak (Fig. 6C). 
Interestingly, exactly the same alteration in unbinding signature (Fig. 6C) and reduced cell elasticity (Fig. 6B) 
were observed when CHO-DC-SIGN-WT cells were pre-treated with cytochalasin D (CytD) to disturb actin 
polymerization. This indicates a potential role of galectins in stabilizing DC-SIGN contacts probably due to indi-
rectly linking them to the actin cortex.
Discussion
In this study, exploiting AFM-assisted adhesion measurements between two individual cells, we measured the 
strength with which a single cell expressing the pathogen-recognition receptor DC-SIGN binds a single fungal 
Candida albicans cell and we determine a novel role for DC-SIGN N-glycosylation. We find that during dynamic 
interactions DC-SIGN accounts for 50% of the initial binding of Candida to imDCs. Moreover, the organiza-
tion of DC-SIGN on the cellular membrane by tetramerization as well as glycan-mediated lateral interactions 
is important to strengthen adhesion to pathogenic fungal cells under mechanical load. This study, therefore, 
puts forward a very interesting role for the glycocalyx as extracellular cytoskeleton contributing, possibly in 
Figure 3. AFM-assisted cell-cell force spectroscopy to measure the interaction strength of single CHO-DC-
SIGN cells and C. albicans. (A) Parental CHO cells and cells expressing DC-SIGN-WT were incubated with 
FITC-labeled C. albicans in the presence or absence of blocking agents; anti-DC-SIGN antibody and EDTA. The 
percentage of cells that bound C. albicans was calculated by flow cytometry. Data are presented as means ± S.D. 
(B) Schematic set-up showing a single C. albicans cell immobilized on a tip-less AFM cantilever interacting with 
a CHO-DC-SIGN cell. (C) Example brightfield image that shows how a C. albicans cell on the tip (indicating 
by dashed white ellipse) is positioned to interact with four different CHO-DC-SIGN cells. The positions at 
which the C. albicans is brought into contact are indicated by asterisks. (D) Example FD-curves of C. albicans 
interacting with parental CHO, CHO-DC-SIGN-WT with addition of 30 µg/ml anti-DC-SIGN blocking 
antibody for 30 minutes.
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connection with the intracellular actin cytoskeleton, to optimize strengthening of cell-pathogen interactions in 
the presence of mechanical forces.
Here, we wanted to gain more insight in the dynamical interaction strength of DC-SIGN recognizing C. albi-
cans. In previous experiments using flow cytometry, we have demonstrated that imDCs bind and internalize C. 
albicans through the CLRs DC-SIGN and MMR20, 47. These earlier experiments showed that MMR might be the 
main contributor to binding, where DC-SIGN plays a secondary role. By contrast, our CCFS results now show 
that DC-SIGN contributes up to 50% to preserve binding to Candidas under dynamic conditions. Except of a 
difference in scale, i.e. 100,000 s vs. single cells, a more prominent difference is that flow cytometry is performed 
under static conditions whereas CCFS measures adhesion under mechanical load comparable to the physiolog-
ical conditions during infection of the host. Thus, the role of DC-SIGN on imDCs in capturing Candidas might 
become more apparent when mechanical forces act at the interaction site, which is at the order of only tens of µm² 
and depends on dwelling time and Candida size. By applying physiological pulling forces on the pathogens using 
an AFM cantilever, we determined a capturing strength of 1–4 nN by DC-SIGN molecules after only 10 seconds 
of contact with single unbinding events of 105–110 pN each, probably related to the high discriminative bind-
ing capacity of DC-SIGN for pathogenic carbohydrates22, 24, 34. These interactions forces are comparable though 
slightly lower than those of C. albicans and macrophages that range between 0.25–3.0 nN for the same interaction 
time and can primarily be attributed to MMR-mediated interactions43. However, MMR expression level differ-
ences might differ between these macrophages and our imDCs making a fair comparison difficult.
Earlier studies attributed the binding of C. albicans to the carbohydrate recognition domain (CRD) of 
DC-SIGN and to the α-(1,2) branched mannose residues21, 47. Moreover, we recently showed by AFM force spec-
troscopy studies that slight differences in the N-mannan structure of Candida, such as, the absence or presence 
of a phosphomannan side chain, can be recognized by DC-SIGN34. Next to the specific affinity of DC-SIGN’s 
CRD domain for specific pathogenic sugars, another level of binding strength control exploited by DC-SIGN is 
Figure 4. Contribution of the different domains of DC-SIGN to the interaction with C. albicans. (A) CHO cells 
expressing the different DC-SIGN mutants were incubated with FITC-labeled C. albicans cells in the presence 
or absence of EDTA. The percentage of cells that bound C. albicans was calculated by flow cytometry. Data are 
presented as means ± S.D. (B) Example FD-curves of C. albicans interacting with CHO-DC-SIGN-WT with 
and without blocking Ab, CHO-DC-SIGN-ΔCRD, CHO-DC-SIGN-N80A, or CHO-DC-SIGN-ΔRep cells. 
(C,D) The detachment force (C) and work (D) needed to detach an C. albicans cell from the CHO cells stably 
expressing DC-SIGN-WT before and after blocking by anti-DC-SIGN, and CHO cells stably expressing DC-
SIGN-ΔCRD, DC-SIGN-N80A, or DC-SIGN-ΔRep (N ≥ 3 independent experiments; N ≥ 20 cells; N ≥ 20 FD-
curves per condition). Significance levels by Mann-Whitney (n.s. = not significant; **p<0.01; ***p<0.001). (E) 
Probability distribution of all rupture steps detected in the FD-curves of DC-SIGN-WT, DC-SIGN-N80A, and 
DC-SIGN-∆Rep interacting with C. albicans show different distributions that all peak around 110 pN (N > 2000 
rupture steps). The normalized probability plots are shown and the ‘dashed’ curves are scaled relative to the 
number of rupture steps per FD-curve (arbitrary units).
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its intrinsic tetramerization22 and its tendency to form nanoclusters on the cellular membrane9. Structural studies 
showed that DC-SIGN forms tetramers through its repeat regions bringing four CRDs in proximity49, 52. In the 
study described here, it is likely that all CRDs bind ligands present in the mannan structures of C. albicans outer 
cell wall, and thereby support cooperative affinity of the bonds, i.e., avidity. Indeed, we observed that mutant 
DC-SIGN molecules expressed on CHO cells without their repeat region (DC-SIGN-∆Rep) adhered weaker to C. 
albicans (Fig. 4). Earlier studies showed that DC-SIGN-∆Rep is not in nanoclusters and is present as monomers 
on the cellular membrane10, 23. Therefore, it may lack the capacity to increase binding strength by cooperative 
binding and thus shows a weaker adhesion. Moreover, when present on the plasma membrane as tetramer, i.e., as 
WT or N80A, DC-SIGN is more prone to form membrane tethers over long distances (Fig. 5), probably, because 
a tetramer of DC-SIGN anchoring a membrane tether with four bonds has a longer lifetime than a monomeric 
DC-SIGN bond53. All these subtle differences between DC-SIGN mutants could not be picked up by studying 
binding by flow cytometry, i.e., without any mechanical force involved, highlighting the power of AFM-assisted 
CCFS.
Recent work of our group provided evidence that N-glycan-mediated membrane micropatterning plays a 
role in organizing DC-SIGN molecules in clathrin-enriched regions to induce phagocytosis of pathogens29. 
Removal of N-glycans from DC-SIGN or neutralization of DC-SIGN-galectin interactions by lactose indicated 
that galectin-9 might be the glycan-binding protein that links DC-SIGN to the trans-membrane glycoprotein 
CD4429. Both galectin-9 and CD44 were found together with DC-SIGN on imDCs phagosomes54. In the study 
described here, we explored the correspondence of N-glycan-mutated DC-SIGN (DC-SIGN-N80A) binding to 
C. albicans by dynamically pulling the fungal cell away from the DC-SIGN-expressing cell (Figs 5 and 6). When 
the N-glycosylation site is abrogated or binding by galactin-9 blocked by lactose, we observe that the adhesion 
structure is less stable: i) the detachment force Fmax is lower, and ii) the elasticity is smaller when we pull on 
the adhesive structure formed between cell and pathogen, probably because DC-SIGN loses its indirect link-
ing to the actin cortex (Fig. 6D). Earlier, we hypothesized that galectin-9 connects DC-SIGN to CD44 through 
glycan-protein-mediated linkages and may thereby indirectly link DC-SIGN to the actin cytoskeleton29, because 
CD44 is known to associate with actin13. This may explain how DC-SIGN can be maintained in clathrin-rich 
regions and support phagocytosis of pathogens. The results showed here support this hypothesis.
In summary, we demonstrate to the best of our knowledge for the first time how the strength of AFM can 
be exploited to bring a single C. albicans cell into contact with a single primary phagocytic cell of the immune 
system to study the recognition of this pathogen by the pathogen-recognition receptor DC-SIGN expressed on 
an imDC. We show that DC-SIGN exploits different mechanisms to strengthen adhesion after recognition. Apart 
from tetramerization and the formation of microdomains of the receptor that supports a longer lifetime of bonds, 
Figure 5. Tetrameric DC-SIGN contributes to more membrane tethers per retraction. (A,B) Averaged FD-
curves of CHO cells expressing DC-SIGN-WT, DC-SIGN-N80A, DC-SIGN-ΔCRD, and DC-SIGN-ΔRep 
(N ≥ 20 cells) were generated by averaging N ≥ 100 FD-curves. For averaging, FD-curves were aligned on the 
maximum detachment peak (A) or on the 2 nN position (B). (C) The number of membrane tether rupture 
events observed per retraction of a C. albicans cell being detached from a CHO cell expressing either DC-
SIGN-WT, DC-SIGN-N80A, DC-SIGN-ΔCRD, or DC-SIGN-ΔRep (N ≥ 20 cells; N ≥ 100 FD-curves). Data 
are presented as means ± S.D.
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also N-glycan-mediated linkages help to support firm binding of the pathogen probably by indirect linkage to the 
actin cortex through membrane-organizing galectins that bind N-glycosylated DC-SIGN at one side and CD44 
or other cell adhesion molecules on the other side. This dynamic strengthening of the adhesion by the model 
proposed here might facilitate internalization of the pathogen upon binding. Moreover, our single cell-cell exper-
iments show that the immune receptor DC-SIGN is very well capable of recognizing pathogens under dynamic 
conditions and thus protecting the human body from fungal infections. Finally, the interesting observation that 
N-glycosylation of a CLR might support pathogen recognition could include N-glycan as future emerging targets 
in anti-microbial therapies, while also conveying novel concepts to the cell adhesion and mechano-biological 
fields.
Methods
Antibodies and blocking agents. Anti-DC-SIGN (AZN-D1) mouse monoclonal antibody was produced 
as already described15. Anti-DC-SIGN antibody DCN46 was from BD Pharmingen. Mannan derived from 
Candida albicans (CA-mannan) and Saccharomyces cerevisiae (SC-mannan) were kind gifts from Dr. G. Kogan 
(Institute of Chemistry of Slovak Academy of Sciences, Bratislava, Slovakia)55. The Ca2+/Mg2+-chelators EDTA 
and EGTA as well as the lactose and were from Sigma Aldrich.
Candida albicans. C. albicans, strain CAI-4 serotype A, a well described clinical isolate56, were grown as 
reported elsewhere57. Briefly, starter cultures were grown in 10 ml of Sabouraud broth overnight at 30 °C. 1 ml of 
overnight culture was inoculated into 100 ml of Sabouraud broth and cultured at 30 °C until log phase is reached. 
After two washes with pyrogen-free saline by centrifugation at 1500 × g, the number of yeast cells was counted 
Figure 6. N-glycosylation of DC-SIGN contributes to a more resistant adhesion site. (A) Zoom in to the 
averaged FD-curves of CHO cells expressing DC-SIGN-WT, DC-SIGN-N80A, DC-SIGN-ΔCRD, and DC-
SIGN-ΔRep of Fig. 5B. Dotted lines indicate semi-linear fits to the slope before of the retraction curve until 
maximum force is reached at Fmax (i.e., contact region) from averaged retraction FD-curves DC-SIGN-WT and 
DC-SIGN-N80A. (B) The elasticity for cells expressing the different DC-SIGN-constructs, CHO-DC-SIGN-WT 
treated by lactose or CytD; measured by fitting the linear slope presented in (A). (C) Averaged FD-curves of 
CHO-DC-SIGN-WT cells untreated, cultured for 24 h in 100 mM lactose, or treated with 10 µM of the actin 
polymerization inhibitor CytD compared to CHO-DC-SIGN-N80A cells (N ≥ 15 cells; N ≥ 80 FD-curves). (D) 
Cartoon depicting the interaction between C. albicans and DC-SIGN and the role played by the N-glycans in 
strengthening pathogen-binding. When DC-SIGN nanoclusters bear N-glycans (1), they can laterally interact 
with transmembrane proteoglycans such as CD44, through galectin-mediated cross-linking. Molecules such as 
CD44 are almost stably associated with cortical actin, thus providing a structural scaffold that might facilitate 
DC-SIGN-actin interactions. The absence of the N-glycans (such as in N80A or after lactose treatment) prevents 
DC-SIGN-galectin interaction (2), thus hampering the possibility to firmly link to the actin cytoskeleton. The 
N-glycan-galectin network at the outer leaflet of the plasma membrane and, therefore, adds an extra level of 
binding strengthening during DC-SIGN-pathogen interactions, which is distinct yet connected to the cortical 
actin polymerization.
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in a hemocytometer and resuspended at 1 × 108 cells/ml. Heat-inactivation was at 56 °C for 1 h. Yeast cell suspen-
sions were kept frozen at −80 °C until used. Labeling of Candida cells was performed as follows: yeast cells were 
resuspended to 2 × 108 cells/ml, in 0.01 mg/ml FITC (Fluka) in 0.05 M carbonate-bicarbonate buffer (pH 9.5). 
After incubation for 15 min at room temperature in the dark, FITC-labeled Candida cells were washed twice in 
PBS containing 1% BSA20.
Cell culture. CHO cell lines stably expressing DC-SIGN wild-type, DC-SIGN-N80A, -ΔRep, and -ΔCRD 
mutants, were established by Lipofectamin 2000 (Invitrogen) transfection, and were cultured in Ham’s F-12 
medium (LabClinics) supplemented with 10% heat-inactivated FBS (Invitrogen), 1% Antibiotic Antimycotic 
Solution (GE Healthcare Life Sciences), and 0.5 mg/ml of the aminoglycoside antibiotic G418 (Invitrogen)58. 
To note, the use of CHO cells expressing DC-SIGN wild-type or mutant has been already validated in previ-
ous publications9, 10, 20, 29, 47, 48. Human immature dendritic cells (imDCs) were generated from peripheral blood 
monocytes of healthy donors as reported elsewhere15, and cultured in RPMI, 10% FBS, 1% antibiotic-antimycotic 
solution supplemented with 800 U/ml granulocyte-macrophage colony-stimulating factor (GM-CSF), and 500 U/
ml Interleukin-4 (IL-4).
Candida binding studies. The binding of stable CHO transfectants expressing DC-SIGN to Candida 
yeast cells was measured by flow cytometry using the FACS Calibur (BD Biosciences) and performed as earlier 
described15, 20. To test the effect of various reagents on ligand binding the following reagents were used: different 
carbohydrates at 150 μg/ml, EDTA at 2 mM, anti-DC-SIGN antibody AZN-D1 at 30 μg/ml. Incubations were per-
formed in TSM (20 mM Tris, 150 mM NaCl, 1 mM CaCl2, 2 mM MgCl2, pH 8.0), and 1% bovine serum albumin, 
as already published20. FITC-labeled Candida was added in a cell/yeast ratio of 1:10. After 20 min of incubation at 
37 °C, cell-yeast conjugates were analyzed by flow cytometry.
AFM and cantilevers. Force measurements were made in force-distance mode using a combined BioScope 
Catalyst AFM (Bruker, Santa Barbara, CA) and an inverted 3-channel Leica TCS SP5 II confocal laser-scanning 
microscope equipped with an 40 × 0.85NA air objective and Hamamatsu (ORCA-05G) brightfield camera. 
The AFM was equipped with a temperature controller to keep temperature stable at 37 °C. Triangular tipless 
gold-coated silicon-nitride cantilevers were used with nominal spring constants of 0.06 N/m as given by the man-
ufacturer (NP-O type D, Bruker). Each cantilever was calibrated before use by the thermal noise calibration 
method59, 60.
Immobilization of C. albicans on AFM cantilevers. C. albicans cells with a diameter of 4.7 ± 0.4 µm 
were attached to tipless AFM cantilevers that were coated by concanavalin A (ConA; Sigma) essentially as 
described earlier33. ConA-coated cantilevers were prepared as follows: cantilevers were cleaned by immersion 
in pure 18 M sulphuric acid (Sigma) for 1 hour, then thoroughly rinsed with Milli-Q water, ethanol and after a 
final rinse in Milli-Q water let to dry. Following an overnight incubation at 4 °C in ConA at 2 mg/ml in PBS, the 
cantilevers were rinsed and stored in PBS for no more than one day. Intact C. albicans cells kept in TSM were 
seeded into the liquid chamber of the AFM containing serum-free culture medium plus 10 mM HEPES. The 
optical microscope mounted on the AFM was hereby used to position the ConA-functionalized cantilever over 
a target C. albicans cell. Subsequently, contact was established between cantilever and cell for at least 10 seconds. 
During this time, the applied indentation force was kept constant at about 5 nN. Upon retraction, the successful 
pick-up was readily scored by visual inspection, and, in these events, the fungal cell was positioned on the apex 
of the cantilever (Fig. 2B).
Adhesion measurements and analysis. The cantilever with the Candida cell was brought into contact 
with imDCs or CHO cells expressing DC-SIGN for a preset period of time (an interaction time of 10 seconds) 
on the Catalyst AFM. During this time, a force was exerted on the cell of 2 nN. Upon retraction at 15 µm/s, 
the forces acting on the cantilever were recorded as a function of displacement of the cantilever from the sub-
strate in force-distance (F-D) curves. DC-SIGN-Candida rupture forces were determined directly from rupture 
steps in the FD-curves (see Fig. 2C). The detachment force (Fmax) was measured by determining the force differ-
ence between minimum force and the baseline when zero force acts on the cantilever. The area enclosed by the 
zero-force baseline and the FD-curve (Fig. 2C) was taken as a measure for the work (W = F·d) needed to detach 
the contact61. Specificity was verified by an in situ incubation with the DC-SIGN-specific monoclonal antibody 
AZN-D1 (30 µg/ml), soluble CA-mannan (150 µg/ml), and EDTA (2 mM) for 30 minutes. Candida cells were 
brought into contact with flat parts at the periphery of imDCs or CHO cells. Whenever appropriate, cells were 
treated with growth medium containing 100 mM of lactose for a minimum of 24 h, to disrupt glycan-dependent 
interactions mediated by cell surface galectins29, 62. To disrupt the actin cytoskeleton, cells were treated with 10 µM 
cytochalasin D for 30 min.
Acquired data were exported from the BioScope Catalyst by the NanoScope Version 8.15 software and further 
analyzed in MATLAB and IgorPro using in-house analysis macros33, 37. Data were analyzed in a similar way as 
described earlier33. In short, rupture steps were detected by the macro, steps that were at distances >5 µm from 
the cell were defined as membrane tethers, FD-curves were averaged at the position of maximal adhesion (Fmax) 
or at 2 nN force (contact force), and stiffness was calculated by a linear fit to the 1nN-to-Fmax regime. Origin and 
GraphPad Prism were used for fitting and statistics.
Data availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
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